Trials

1. Biederman, et al. J Child and Adolescent Psychopharmacol 2000;10:185-92. 
2. Bottlender et al. J Affective Disorders 2001;63:79-83.
3. Ghaemi SN, et al. J Affective Disorders 1999;52:135-44. 
4. Gyulai L, et al. Neuropsychopharmacology 2003;28:1374-82. 
5. Henry, et al. J Clin Psychiatry 2001;62:249-55. 
6. Morishita S and Arita S. Hum Psychopharmacol Clin Exp 2003;18:565-8. 
7. Post RM, et al. Bipolar Disorders 2001;3:259-65. 
8. Preda et al. J Clin Psychiatry 2001;62:30-3.
9. Serretti A et al. Prog Neuropsychopharmacol Biol Psychiatry 2003;27:751-7.
10. Nemeroff et al. Am J Psychiatry 2001;158:906-12. 
11. Tohen, et al. Arch Gen Psychiatry 2003;60:1079-88. Also: Keck et al. Focus on rapid cycling. World J Psychiatry 2004;(Suppl 1):50. [congress abstract]
12. Vieta, et al. J Clin Psychiatry 2002;163:508-12.
13. Young et al. Am J Psychiatry 2000;157:124-6.

• WFSBP:
  Grunze, et al. World J Biol Psychiatry 2003; 4:5-13.
• Danish Guidelines:
  Licht, et al. Acta Psychiatr Scand 2003;108(S419):1-22. 
• Australian Guidelines:
  Mitchell PB, et al. Australasian Psychiatry 11(1):39-53.
• BAP Guidelines:
  Goodwin, et al. J Psychopharmacol 2003;17:149-73.
• APA Guidelines:
  Hirschfeld, et al. Am J Psychiatry 2002;159(4 Suppl):1-50.
• ICG Guidelines:
  J Clin Psychiatry 2004;65:(In press).